Latest news and articles about Lilly from NEX English
Lilly has announced the launch of a new obesity treatment, generating significant interest on Wall Street despite strong competition from Novo Nordisk. The drug is expected to achieve sales in the billions.
Lilly, the American pharmaceutical giant, has announced its acquisition of a company specializing in the development of a drug for narcolepsy, in a deal valued at up to <strong>$7.8 billion</strong>. This move aims to expand the company's market presence and enhance its drug portfolio.